EDGAR Filing Documents for 0001140361-18-038676

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:

SEC Accession No. 0001140361-18-038676

Filing Date

2018-09-18

Accepted

2018-09-18 17:11:16

Documents

Effectiveness Date

2018-09-18

Document Format Files

Seq	Description	Document	Type	Size
1	S-3ASR	s002406x1_s3asr.htm	S-3ASR	567997
2	EXHIBIT 4.4	s002406x1_ex4-4.htm	EX-4.4	382003
3	EXHIBIT 4.7	s002406x1_ex4-7.htm	EX-4.7	113799
4	EXHIBIT 4.8	s002406x1_ex4-8.htm	EX-4.8	114272
5	EXHIBIT 4.9	s002406x1_ex4-9.htm	EX-4.9	103882
6	EXHIBIT 5.1	s002406x1_ex5-1.htm	EX-5.1	28874
7	EXHIBIT 23.1	s002406x1_ex23-1.htm	EX-23.1	2896
8		image0.jpg	GRAPHIC	32202
9		image1.jpg	GRAPHIC	28720
10		logo_akcea.jpg	GRAPHIC	16287
	Complete submission text file	0001140361-18-038676.txt		1421279

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010

Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732

AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)